Detection and Delineation of Necrotizing Fasciitis Via a Vascular Perfusion Fluorophore

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

April 5, 2021

Primary Completion Date

December 4, 2024

Study Completion Date

December 4, 2024

Conditions
Necrotising Fasciitis
Interventions
DRUG

Indocyanine green solution

Patients with clinical suspicion of necrotizing fasciitis would receive a weight-appropriate IV dose of indocyanine green (ICG, FDA-approved) with immediate fluorescence imaging of the affected body part and simultaneous imaging of an unaffected region

Trial Locations (1)

03766

Dartmouth-Hitchock, Lebanon

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT04839302 - Detection and Delineation of Necrotizing Fasciitis Via a Vascular Perfusion Fluorophore | Biotech Hunter | Biotech Hunter